PRKAA2 and cardiac hypertrophy: In 2010, Jiang et al. [86] discovered that the α-Thr172 phosphorylation site of AMPK is inhibited following increased α-Ser485/491 phosphorylation site of AMPK in the setting of AngII-induced cardiac hypertrophy [86].